Previous 10 | Next 10 |
Halozyme to Participate in the 2021 Cantor Virtual Global Healthcare Conference PR Newswire SAN DIEGO , Sept. 15, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Elaine Sun , senior vice president and chief financial ...
Fundamental Research Corp has issued a report entitled "Halo Collective Inc.(NEO: HALO / OTCQX: HCANF / GERMANY: A9KN) Q2 Revenue up 74% YoY / Spin-Off Transaction to Be a Catalyst" and dated August 27, 2021. To read a summary of the key highlights, or to login and download the full analyst r...
Halozyme to Present at Wells Fargo 2021 Virtual Healthcare Conference PR Newswire SAN DIEGO , Aug. 26, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley , president and chief executive officer, will pre...
The following slide deck was published by Halozyme Therapeutics, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Halozyme Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation
Image source: The Motley Fool. Halozyme Therapeutics, inc (NASDAQ: HALO) Q2 2021 Earnings Call Aug 9, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Halozyme Therapeutics, inc (HALO) Q2 2021 Earnings Call Transcrip...
Halozyme Therapeutics, Inc. (HALO) Q2 2021 Earnings Conference Call August 09, 2021, 04:30 PM ET Company Participants Al Kildani - Vice President of Investor Relations and Corporate Communications Helen Torley - President and CEO Elaine Sun - CFO Conference Call Participants Charles Duncan - ...
Halozyme Reports Second Quarter 2021 Results - Raising 2021 Revenue Guidance to $425-$445 Million from $375-$395 Million, GAAP Earnings Per Share Guidance to $1.55-$1.70 from $1.25-$1.40 and Non-GAAP Earnings per Share Guidance to $1.85-$2.00 from $1.55-$1.70 - - Second Quar...
Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference PR Newswire SAN DIEGO , July 30, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Elaine Sun , senior vice president and chief financial officer, wi...
Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call PR Newswire SAN DIEGO , July 27, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2021 on ...
Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse - Janssen's DARZALEX FASPRO® Now the F...
News, Short Squeeze, Breakout and More Instantly...
Halozyme Therapeutics Inc. Company Name:
HALO Stock Symbol:
NASDAQ Market:
Halozyme Therapeutics Inc. Website:
Halozyme to Report Second Quarter 2024 Financial and Operating Results PR Newswire SAN DIEGO , July 23, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2024 financial and operating re...
2024-07-22 03:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...